- Home
- DWTX vs APTO Comparison
DWTX vs APTO Comparison
Compare DWTX & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DWTX
- APTO
- Stock Information
- Founded
- DWTX 2012
- APTO 1986
- Country
- DWTX United States
- APTO Canada
- Employees
- DWTX N/A
- APTO N/A
- Industry
- DWTX
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DWTX
- APTO Health Care
- Exchange
- DWTX NYSE
- APTO Nasdaq
- Market Cap
- DWTX 5.9M
- APTO 6.8M
- IPO Year
- DWTX N/A
- APTO N/A
- Fundamental
- Price
- DWTX $4.20
- APTO $1.71
- Analyst Decision
- DWTX
- APTO Strong Buy
- Analyst Count
- DWTX 0
- APTO 3
- Target Price
- DWTX N/A
- APTO $112.00
- AVG Volume (30 Days)
- DWTX 3.1M
- APTO 58.8K
- Earning Date
- DWTX 03-31-2025
- APTO 05-13-2025
- Dividend Yield
- DWTX N/A
- APTO N/A
- EPS Growth
- DWTX N/A
- APTO N/A
- EPS
- DWTX N/A
- APTO N/A
- Revenue
- DWTX N/A
- APTO N/A
- Revenue This Year
- DWTX N/A
- APTO N/A
- Revenue Next Year
- DWTX N/A
- APTO N/A
- P/E Ratio
- DWTX N/A
- APTO N/A
- Revenue Growth
- DWTX N/A
- APTO N/A
- 52 Week Low
- DWTX $1.62
- APTO $1.35
- 52 Week High
- DWTX $29.28
- APTO $50.10
- Technical
- Relative Strength Index (RSI)
- DWTX N/A
- APTO 31.15
- Support Level
- DWTX N/A
- APTO $3.20
- Resistance Level
- DWTX N/A
- APTO $3.43
- Average True Range (ATR)
- DWTX 0.00
- APTO 0.44
- MACD
- DWTX 0.00
- APTO -0.10
- Stochastic Oscillator
- DWTX 0.00
- APTO 31.60
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc formerly Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM) and Long-COVID (LC). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.